Infliximab: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* TNF-α inhibitor using human-murine chimeric monoclonal antibody * Indications include RA and Crohn disease * Infectious complications include..." |
(No difference)
|
Latest revision as of 00:46, 17 March 2022
- TNF-α inhibitor using human-murine chimeric monoclonal antibody
- Indications include RA and Crohn disease
- Infectious complications include TB, NTM, histoplasmosis, candidiasis, listeriosis, aspergillosis, cryptococcosis, nocardiosis, salmonellosis, toxoplasmosis, brucellosis, bartonellosis, leishmaniasis, coccidiomycosis, CMV, and leprosy
